




Instance: composition-en-5a0e77a26a98f2eac352c48d66309743
InstanceOf: CompositionUvEpi
Title: "Composition for lumeblue Package Leaflet"
Description:  "Composition for lumeblue Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "EU/1/20/1470/001"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mp5a0e77a26a98f2eac352c48d66309743)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - lumeblue"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional

  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>unavailable</div>"""
  * emptyReason = http://terminology.hl7.org/CodeSystem/list-empty-reason#unavailable   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>unavailable</div>"""
  * emptyReason = http://terminology.hl7.org/CodeSystem/list-empty-reason#unavailable   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is in this leaflet</p>
<ol>
<li>What Lumeblue is and what it is used for  </li>
<li>What you need to know before you take Lumeblue  </li>
<li>How to take Lumeblue </li>
<li>Possible side effects  </li>
<li>How to store Lumeblue </li>
<li>Contents of the pack and other information </li>
</ol> </div>"""   
          

* section[=].section[+]
  * title =  "1. What lumeblue is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What lumeblue is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Lumeblue contains methylthioninium chloride (also known as methylene blue). This medicine is a 
blue dye.  </p>
<p>This medicineis used in adults to temporarily stain the colon (large bowel) before colonoscopy, in 
which a flexible instrument is inserted into the rectum to view inside the bowel. The staining allows 
the doctor to see the lining of the colon more clearly and improves the detection of abnormalities.  </p> </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take lumeblue"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take lumeblue"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Do not take Lumeblue 
* if you are allergic to methylthioninium chloride, peanut or soya, or any of the other 
ingredients of this medicine (listed in section 6);<br />
* if you have been told you have glucose-6-phosphate dehydrogenase (G6PD) deficiency; 
* if you are pregnant or think you may be pregnant, or are breastfeeding as your doctor may 
decide that you do not need to take this medicine before your procedure.  </p>
<p>Warnings and precautions<br />
Talk to your doctor or pharmacist before taking this medicine: 
* If you are taking certain antidepressant medicine or a medicine for psychiatric illness. Such as:</p>
<ul>
<li>selective serotonin reuptake inhibitor (SSRI) antidepressants such as fluoxetine, 
fluvoxamine, paroxetine, sertraline, citalopram, escitalopram and zimeldine; </li>
<li>bupropion, venlafaxine, mirtazapine, clomipramine, buspirone; </li>
<li>medicines classified as monamine oxidase inhibitors (often used for treating depression). 
Giving methylthioninium chloride injection (into a vein) in patients also taking these medicines 
has sometimes resulted in a life-threatening complication called serotonin syndrome. It is not 
known if serotonin syndrome can occur when methylthioninium chloride is given as a tablet. 
Your doctor will decide what to do if you are taking an antidepressant or another medicine for a 
psychiatric illness.<br />
Children and adolescents 
Lumeblue should not be given to children and adolescents under 18 years of age as it is not known if 
the medicine is safe and effective in this age group. </li>
</ul>
<p>Other medicines and Lumeblue 
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other 
medicines.  </p>
<p>Other medicines and Lumeblue taken together may affect how they each work or are processed and 
removed from the body. </p>
<p>In addition to antidepressants and the other medicines for psychiatric illness mentioned under 
 Warnings and Precautions , you should tell your doctor before you take this medicine if you are also 
taking or have recently been given: 
* Medicines to treat irregular heart beats such as amiodarone, digoxin and quinidine 
* Warfarin, to prevent blood clots<br />
<em> Medicines to treat cancer such as alectinib, everolimus, lapatinib, nilotinib and topotecan<br />
</em> Medicines to prevent organ transplant rejection such as ciclosporin, sirolimus and tacrolimus 
* Medicines to treat HIV infection such as ritonavir and saquinavir 
* Medicines to treat migraine such as dihydroergotamine, ergotamine 
* Medicines used to treat anxiety or insomnia, such as diazepam 
* Sedative medicines such as midazolam and propofol<br />
<em> Antihistamine medicines to treat allergies such as diphenhydramine or promethazine 
* Probenecid to treat gout 
* Phenytoin to treat epilepsy 
* Pimozide to treat psychosis or schizophrenia 
* Medicines to treat severe pain such as alfentanil, fentanyl and pethidine (also known as 
meperidine) 
* Cimetidine to treat stomach ulcers and acid reflux 
* Metformin to treat type 2 diabetes<br />
</em> Aciclovir to treat herpes simplex virus infections (e.g. cold sores, genital warts) and varicella 
zoster virus infections (e.g. chicken pox, shingles) </p>
<p>Pregnancy and breast-feeding<br />
If you are pregnant, think you may be pregnant or are planning to have a baby, do not use Lumeblue as 
it is not known whether this medicine can harm your unborn baby. 
If you are breast-feeding, ask your doctor or pharmacist for advice before taking this medicine.<br />
Your doctor may decide that you do not need to take this medicine if you require a colonoscopy whilst 
breast-feeding. </p>
<p>Driving and using machines 
It is unlikely that taking Lumeblue will affect your ability to drive or use machines. However if you 
experience any side effects that could impair your ability to drive or use machines safely, such as 
migraine, feeling dizzy, or disturbance to your vision, then you should not drive or use machines until 
you feel better. </p>
<p>Lumeblue contains soya lecithin 
If you are allergic to peanut or soya, do not take this medicine. </p> </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take lumeblue"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take lumeblue"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor 
or pharmacist if you are not sure. </p>
<p>The medicine is supplied as tablets. These must be swallowed whole because they have a special 
coating to make sure that they pass through your stomach and only break up in your intestines to 
release the methylthioninium chloride that stains the colon blue. You must not crush or chew them. </p>
<p>You will be given a pack containing 8 tablets (a total of 200 mg methylthioninium chloride). These 
must all be taken over a period of 2 hours, the night before your colonoscopy. Your doctor will explain 
how you should take the tablets, which are normally taken together with a bowel cleansing preparation 
(a medicine to clear out your colon).  </p>
<p>Take the tablets as instructed by your doctor.  </p>
<p>Typical instructions are: </p>
<ol>
<li>
<p>After drinking at least 1 litre of the bowel cleansing preparation (or water) take the first dose of 
3 tablets. </p>
</li>
<li>
<p>Wait 1 hour then take the second dose of 3 tablets.  </p>
</li>
<li>
<p>Wait another hour, then take the final dose of 2 tablets. </p>
</li>
</ol>
<p>If you take more Lumeblue than you should 
The box contains one complete dose of Lumeblue. Therefore you cannot take more Lumeblue than 
you should. However, if you take more tablets than you should, you might get some of the side effects 
listed in section 4. If you think you have taken more of this medicine than you should, tell your doctor 
or nurse as soon as possible.<br />
If you notice any of the following symptoms you should tell your doctor straight away: 
* Feeling or being sick, or stomach pain 
* Abnormally fast beating of the heart, or chest pain 
* Tight chest or difficulty breathing (e.g. breathlessness) 
* Confusion, dizziness, or headache 
* Sweating, tremor, feeling weak, paler skin than usual, or skin turning blue </p>
<p>An increase in methaemoglobin (an abnormal form of haemoglobin in the blood); </p>
<p>High blood pressure. </p>
<p>If you forget to take one or more of the doses of Lumeblue 
Do not take a double dose to make up for a forgotten tablets, take the next dose of tablets according to 
the bowel cleansing schedule given to you by your doctor, it may be helpful to set an alarm to remind 
you when to take the medicine.  </p>
<p>If you stop taking Lumeblue 
At your colonoscopy, tell your doctor that you did not take all the tablets.<br />
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse. </p> </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. </p>
<p>The following side effects are common, but tell your doctor or nurse if you are worried about any side 
effect you get: </p>
<p>Very common (may affect more than 1 in 10 people) 
* Discoloured urine 
* Discoloured faeces 
* Dizziness 
* Changes in your sense of taste 
* Pins and needles sensation, tingling or prickling 
* Pain or discomfort in your hands or feet 
* Blue discolouration of the skin 
* Sweating </p>
<p>Common (may affect up to 1 in 10 people) 
* Nausea 
* Vomiting 
* Stomach or chest pain 
* Headache 
* Anxiety </p>
<p>Uncommon (may affect up to 1 in 100 people) 
* Cold-like symptoms, including blocked or runny nose 
* Migraine 
* Low blood pressure 
* Cough 
* Vomiting blood 
* Bruising-like discolouration of the skin,<br />
* Night sweats 
* Itchy skin 
* Rash 
* Spidery veins 
* Pain in the back or sides 
* Abnormally large amounts of urine, or pain or difficulty when passing urine 
* General pain 
* Chills 
* Signs of serotonin syndrome, such as muscle spasms, clumsiness, tremors, confusion or other 
mental changes 
* Signs of an anaphylactic reaction, such as itchy rash, throat or tongue swelling, shortness of breath. </p>
<p>Reporting of side effects 
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side 
effects not listed in this leaflet. You can also report side effects directly via the national reporting 
system. By reporting side effects you can help provide more information on the safety of this 
medicine. </p> </div>"""      
        
* section[=].section[+]
  * title = "5. How to store lumeblue"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store lumeblue"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this medicine out of the sight and reach of children. </p>
<p>Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date 
refers to the last day of that month. </p>
<p>This medicine does not require any special storage conditions. </p>
<p>Do not use this medicine if the pack is damaged or shows signs of tampering. </p>
<p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to 
throw away medicines you no longer use. These measures will help protect the environment. </p> </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What Lumeblue contains<br />
The active substance is methylthioninium chloride. Each prolonged-release tablet contains 25 mg 
methylthioninium chloride. 
- The other ingredients are: 
* 
Tablet core: stearic acid 50 (E570), soya lecithin (E322)   see section 2 under  Lumeblue contains 
soya lecithin , microcrystalline cellulose (E460), hypromellose 2208 (E464), mannitol (E421), 
talc (E553b), silica colloidal anhydrous (E551), magnesium stearate (E470b) 
* Film coating: methacrylic acid methyl methacrylate copolymer, talc (E553b), titanium 
dioxide (E171), triethyl citrate (E1505) </p>
<p>What Lumeblue looks like and contents of the pack 
Lumeblue prolonged-release tablets are off-white to light blue, round, biconvex, enteric-coated tablets. 
The prolonged-release tablets are provided in blister packs containing 8 tablets.  </p>
<p>Marketing Authorisation Holder 
Alfasigma S.p.A. 
Via Ragazzi del  99, n. 5 
40133 Bologna 
Italy 
+39 0516489info.it@alfasigma.com </p>
<p>Manufacturer 
Cosmo S.p.A 
Via C. Colombo, 1 
20045, Lainate 
Milan,<br />
Italy </p>
<p>This leaflet was last revised in  </p>
<p>Other sources of information </p>
<p>Detailed information on this medicine is available on the European Medicines Agency web site: </p> </div>"""      



Instance: composition-da-5a0e77a26a98f2eac352c48d66309743
InstanceOf: CompositionUvEpi
Title: "Composition for lumeblue Package Leaflet"
Description:  "Composition for lumeblue Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "EU/1/20/1470/001"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mp5a0e77a26a98f2eac352c48d66309743)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - lumeblue"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #da
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. INDLÆGSSEDDEL"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. INDLÆGSSEDDEL"
  * text.status = #additional

  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>unavailable</div>"""
  * emptyReason = http://terminology.hl7.org/CodeSystem/list-empty-reason#unavailable   


      
* section[=].section[+]
  * title = "Indlægsseddel: Information til brugeren"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Indlægsseddel: Information til brugeren"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>unavailable</div>"""
  * emptyReason = http://terminology.hl7.org/CodeSystem/list-empty-reason#unavailable   



* section[=].section[+]
  * title = "Oversigt over indlægssedlen"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Oversigt over indlægssedlen"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Oversigt over indlægssedlen </p>
<ol>
<li>Virkning og anvendelse af Lumeblue, og hvad det bruges til  </li>
<li>Det skal du vide, før du begynder at tage Lumeblue  </li>
<li>Sådan skal du tage Lumeblue </li>
<li>Bivirkninger  </li>
<li>Opbevaring </li>
<li>Pakningsstørrelser og yderligere oplysninger </li>
</ol> </div>"""   
          

* section[=].section[+]
  * title =  "1. Virkning og anvendelse"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. Virkning og anvendelse"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Lumeblue indeholder methylthioniniumchlorid (også kendt som methylenblåt). Denne medicin er et 
blåt farvestof.  </p>
<p>Denne medicin bruges til voksne til midlertidigt at farve tyktarmen før koloskopi, hvor et fleksibelt 
instrument indføres i rektum til visning af tarmens inderside. Farvningen gør det muligt for lægen at se 
tyktarmens foring mere tydeligt og forbedrer identifikationen af abnormiteter.  </p> </div>"""   
          

             
* section[=].section[+]
  * title = "2. Det skal du vide, før du begynder at tage  lumeblue"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. Det skal du vide, før du begynder at tage  lumeblue"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Tag ikke Lumeblue 
- hvis du er allergisk over for methylthioniniumchlorid, jordnødder eller soja eller et af de 
øvrige indholdsstoffer i dette lægemiddel (angivet i punkt 6).<br />
• hvis du har fået at vide, at du har glucose-6-phosphat-dehydrogenase (G6PD)-deficiens; 
• hvis du er gravid eller tror, du kan være gravid, eller hvis du ammer, idet din læge kan beslutte, at 
du ikke behøver at tage denne medicin før din undersøgelse.  </p>
<p>Advarsler og forsigtighedsregler<br />
Kontakt lægen eller apotekspersonalet, før du tager dette lægemiddel: 
• Hvis du tager visse antidepressiva eller medicin mod psykisk sygdom. Såsom:</p>
<ul>
<li>selektiv serotoningenoptagshæmmer (SSRI)-antidepressiva, såsom fluoxetin, fluvoxamin, 
paroxetin, sertralin, citalopram, escitalopram og zimeldin; </li>
<li>bupropion, venlafaxin, mirtazapin, clomipramin, buspiron; </li>
<li>lægemidler klassificeret som Mono-Amino-Oxidase-hæmmere (anvendes ofte til 
behandling af depression). 
Injektion med methylthioniniumchlorid (i en vene) hos patienter, der også tager disse 
lægemidler, har i nogle tilfælde resulteret i en livstruende komplikation kaldet 
serotoninsyndrom. Det vides ikke, om serotoninsyndrom kan forekomme, når 
methylthioniniumchlorid gives som tablet. Lægen beslutter, hvad der skal gøres, hvis du tager et 
antidepressivum eller en anden medicin for psykiatrisk sygdom.  </li>
</ul>
<p>Børn og unge 
Lumeblue bør ikke gives til børn og unge under 18 år, da det ikke vides, om medicinen er sikker og 
effektiv i denne aldersgruppe. </p>
<p>Brug af anden medicin sammen med Lumeblue 
Fortæl altid lægen eller apotekspersonalet, hvis du tager anden medicin, for nylig har taget anden 
medicin eller planlægger at tage anden medicin.  </p>
<p>Brug af anden medicin og Lumeblue sammen kan påvirke, hvordan de hver især fungerer eller 
forarbejdes og fjernes fra kroppen. </p>
<p>Ud over antidepressiva og de andre lægemidler mod psykiatrisk sygdom nævnt under 'Advarsler og 
forholdsregler', bør du, før du tager denne medicin, fortælle lægen, hvis du også tager eller for nylig 
har fået: 
• Medicin til behandling af uregelmæssig hjerterytme såsom amiodaron, digoxin og quinidin 
• Warfarin til forebyggelse af blodpropper<br />
• Medicin til behandling af kræft, såsom alectinib, everolimus, lapatinib, nilotinib og topotecan<br />
• Medicin til at forhindre afstødning af transplanterede organer, såsom ciclosporin, sirolimus og 
tacrolimus 
• Medicin til behandling af HIV-infektion såsom ritonavir og saquinavir 
• Medicin mod migræne såsom dihydroergotamin, ergotamin 
• Medicin til behandling af angst eller søvnløshed, såsom diazepam 
• Beroligende medicin såsom midazolam og propofol<br />
• Antihistamin-medicin til behandling af allergier såsom diphenhydramin eller promethazin 
• Probenecid til behandling af gigt 
• Phenytoin mod epilepsi 
• Pimozid til behandling af psykose eller skizofreni 
• Medicin til behandling af svære smerter såsom alfentanil, fentanyl og pethidin (også kendt som 
meperidin) 
• Cimetidin til behandling af mavesår og tilbageløb af mavesyre 
• Metformin til behandling af type 2-diabetes<br />
• Aciclovir til behandling af herpes simplex-virusinfektioner (f.eks. forkølelsessår, kønsvorter) og 
virusinfektioner med varicella-zoster (f.eks. skoldkopper, helvedesild) </p>
<p>Graviditet og amning<br />
Hvis du er gravid, har mistanke om, at du er gravid, eller planlægger at blive gravid, må du ikke tage 
Lumeblue, da det ikke vides, om dette lægemiddel kan skade dit ufødte barn. 
Hvis du ammer, skal du spørge din læge eller apotekspersonalet til råds, før du tager dette lægemiddel.<br />
Din læge kan beslutte, at du ikke behøver at tage denne medicin, hvis du har brug for en koloskopi, 
mens du ammer. </p>
<p>Trafik- og arbejdssikkerhed 
Det er usandsynligt, at indtagelse af Lumeblue vil påvirke din evne til at køre eller betjene maskiner. 
Men hvis du oplever bivirkninger, der kan påvirke evnen til at køre bil eller betjene maskiner på sikker 
vis, såsom migræne, svimmelhed eller synsforstyrrelse, skal du ikke køre bil eller betjene maskiner, 
før du har det bedre. </p>
<p>Lumeblue indeholder sojalecithin 
Hvis du er allergisk over for jordnødder eller soja, må du ikke tage denne medicin. </p> </div>"""   
                    
* section[=].section[+]
  * title =  "3. Sådan skal du tage lumeblue"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. Sådan skal du tage lumeblue"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Tag altid lægemidlet nøjagtigt efter lægens eller apotekspersonalets anvisning. Er du i tvivl, så spørg 
lægen eller apotekspersonalet. </p>
<p>Medicinen leveres som tabletter. Disse skal sluges hele, fordi de har en speciel belægning, der sikrer, 
at de passerer gennem maven og først brydes i dine tarme, hvor de skal frigive den 
methylthioniniumchlorid, der farver tyktarmen blå. Du må ikke knuse eller tygge dem. </p>
<p>Du får en pakning med 8 tabletter (i alt 200 mg methylthioniniumchlorid). Disse skal alle tages over 
en periode på 2 timer aftenen før din koloskopi. Din læge vil forklare, hvordan du skal tage tabletterne, 
som normalt tages sammen med en tarmrensende opløsning (medicin, der tømmer din tyktarm).  </p>
<p>Tag tabletterne som anvist af lægen.  </p>
<p>Typiske instruktioner er: </p>
<ol>
<li>
<p>Efter at have drukket mindst 1 liter tarmrensende opløsning (eller vand) tages den første dosis på 3 
tabletter. </p>
</li>
<li>
<p>Vent 1 time, hvorefter den anden dosis på 3 tabletter tages.  </p>
</li>
<li>
<p>Vent yderligere 1 time, og tag derefter den sidste dosis på 2 tabletter. </p>
</li>
</ol>
<p>Hvis du har taget for meget Lumeblue 
Æsken indeholder en komplet dosis Lumeblue. Derfor kan du ikke tage mere Lumeblue, end du bør. 
Men hvis du tager flere tabletter, end du bør, kan du få nogle af de bivirkninger, der er anført i punkt 4. Hvis du tror, du har taget mere af denne medicin, end du burde, skal du underrette din læge eller 
sygeplejerske snarest muligt.<br />
Hvis du oplever nogle af følgende symptomer, bør du fortælle din læge det med det samme: 
• Kvalme eller opkastning, eller mavesmerter 
• Unormalt høj puls eller brystsmerter 
• Trykken for brystet eller åndedrætsbesvær (f.eks. åndenød) 
• Forvirring, svimmelhed eller hovedpine 
• Sved, rysten, følelse af svaghed, blegere hud end normalt, eller at huden bliver blå 
• En stigning i methæmoglobin (en abnorm type af hæmoglobin i blodet); 
• Højt blodtryk. </p>
<p>Hvis du har glemt at tage Lumeblue 
Du må ikke tage en dobbeltdosis som erstatning for glemte tabletter. Tag den næste dosis tabletter i 
henhold til den tarmudrensningsplan, du har fået af din læge. Det kan være nyttigt at indstille en alarm, 
der kan minde dig om, hvornår du skal tage medicinen.  </p>
<p>Hvis du holder op med at tage Lumeblue 
Fortæl din læge, når du er til koloskopien, at du ikke har taget alle tabletterne.<br />
Spørg lægen, apotekspersonalet eller sygeplejersken, hvis der er noget, du er i tvivl om. </p> </div>"""         

        
* section[=].section[+]
  * title = "4. Bivirkninger"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Bivirkninger"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Dette lægemiddel kan som alle andre lægemidler give bivirkninger, men ikke alle får bivirkninger. </p>
<p>Følgende bivirkninger er almindelige, men underret lægen eller sygeplejersken, hvis du er bekymret 
over en bivirkning, du får: </p>
<p>Meget almindelige (kan forekomme hos flere end 1 ud af 10 personer) </p>
<ul>
<li>
<p>Misfarvet urin </p>
</li>
<li>
<p>Misfarvet afføring </p>
</li>
<li>
<p>Svimmelhed </p>
</li>
<li>
<p>Ændringer i din smagssans </p>
</li>
<li>
<p>Stikkende fornemmelse, snurren eller prikken </p>
</li>
<li>
<p>Smerter eller ubehag i dine hænder eller fødder </p>
</li>
<li>
<p>Blå misfarvning af huden </p>
</li>
<li>
<p>Svedtendens </p>
</li>
</ul>
<p>Almindelige (kan påvirke op til 1 ud af 10 personer) </p>
<ul>
<li>
<p>Kvalme </p>
</li>
<li>
<p>Opkastning </p>
</li>
<li>
<p>Mave- eller brystsmerter </p>
</li>
<li>
<p>Hovedpine </p>
</li>
<li>
<p>Angst </p>
</li>
</ul>
<p>Ikke almindelige (kan påvirke op til 1 ud af 100 personer) </p>
<ul>
<li>
<p>Forkølelseslignende symptomer, herunder stoppet eller løbende næse </p>
</li>
<li>
<p>Migræne </p>
</li>
<li>
<p>Lavt blodtryk </p>
</li>
<li>
<p>Hoste </p>
</li>
<li>
<p>Opkastning af blod </p>
</li>
<li>
<p>Misfarvning af huden, der ligner blå mærker  </p>
</li>
<li>
<p>Nattesved </p>
</li>
<li>
<p>Kløende hud </p>
</li>
<li>
<p>Udslæt </p>
</li>
<li>
<p>Fremtrædende blodårer </p>
</li>
<li>
<p>Smerter i ryggen eller siderne </p>
</li>
<li>
<p>Unormalt store mængder af urin, eller smerter eller besvær ved vandladning </p>
</li>
<li>
<p>Generel smerte </p>
</li>
<li>
<p>Kuldegysninger </p>
</li>
<li>
<p>Tegn på serotoninsyndrom, såsom muskelspasmer, klodsethed, rystelser, forvirring eller andre 
mentale ændringer </p>
</li>
<li>
<p>Tegn på en anafylaktisk reaktion, såsom kløende udslæt, hals- eller tungehævelse, åndenød. </p>
</li>
</ul>
<p>Indberetning af bivirkninger 
Hvis du oplever bivirkninger, bør du tale med din læge, apotekspersonalet eller sygeplejersken. Dette 
gælder også mulige bivirkninger, som ikke er medtaget i denne indlægsseddel. Du eller dine pårørende 
kan også indberette bivirkninger direkte til Lægemiddelstyrelsen via det nationale 
rapporteringssystem. Ved at indrapportere bivirkninger kan du hjælpe med at fremskaffe mere 
information om sikkerheden af dette lægemiddel. </p> </div>"""      
        
* section[=].section[+]
  * title = "5. Opbevaring"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. Opbevaring"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Opbevar lægemidlet utilgængeligt for børn. </p>
<p>Brug ikke lægemidlet efter den udløbsdato, der står på æsken efter EXP. Udløbsdatoen er den sidste 
dag i den nævnte måned. </p>
<p>Dette lægemiddel kræver ingen særlige forholdsregler vedrørende opbevaringen. </p>
<p>Brug ikke lægemidlet, hvis du bemærker, at pakningen er beskadiget eller viser tegn på manipulation. </p>
<p>Spørg apotekspersonalet, hvordan du skal bortskaffe medicinrester. Af hensyn til miljøet må du ikke 
smide medicinrester i afløbet eller skraldespanden. </p> </div>"""      
        
        
* section[=].section[+]
  * title = "6. Pakningsstørrelser og yderligere oplysninger"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Pakningsstørrelser og yderligere oplysninger"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Lumeblue indeholder<br />
Det aktive stof er methylthioniniumchlorid. Hver depottablet indeholder 25 mg 
methylthioniniumchlorid. 
- Øvrige indholdsstoffer: </p>
<ul>
<li>
<p>Tabletkerne: stearinsyre 50 (E570), sojalecithin (E322) - se punkt 2 under 'Lumeblue indeholder 
sojalecithin', mikrokrystallinsk cellulose (E460), hypromellose 2208 (E464), mannitol (E421), 
talkum (E553b), kolloid vandfri silica (E551), magnesiumstearat (E470b) </p>
</li>
<li>
<p>Filmovertræk: methacrylsyre-methylmethacrylat-copolymer, talkum (E553b), titandioxid (E171), 
triethylcitrat (E1505) </p>
</li>
</ul>
<p>Lumeblues udseende og pakningsstørrelser 
Lumeblue depottabletter er råhvide til lyseblå, runde, bikonvekse, enterisk overtrukne tabletter. 
Depottabletterne leveres i blisterpakninger med 8 tabletter.  </p>
<p>Indehaver af markedsføringstilladelsen 
Alfasigma S.p.A. 
Via Ragazzi del ’99, n. 5 
40133 Bologna 
Italien 
+39 0516489info.it@alfasigma.com </p>
<p>Fremstiller 
Cosmo S.p.A 
Via C. Colombo, 1 
20045, Lainate 
Milano,<br />
Italien </p>
<p>Denne indlægsseddel blev senest ændret i  </p>
<p>Andre informationskilder </p>
<p>Du kan finde yderligere oplysninger om dette lægemiddel på Det Europæiske Lægemiddelagenturs 
hjemmeside: http://www.ema.europa.eu  </p> </div>"""      





                    
Instance: bundlepackageleaflet-en-5a0e77a26a98f2eac352c48d66309743
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for lumeblue Package Leaflet for language en"
Description: "ePI document Bundle for lumeblue Package Leaflet for language en"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #en

// Composition
* entry[0].fullUrl = "Composition/composition-en-5a0e77a26a98f2eac352c48d66309743"
* entry[0].resource = composition-en-5a0e77a26a98f2eac352c48d66309743

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mp5a0e77a26a98f2eac352c48d66309743"
* entry[=].resource = mp5a0e77a26a98f2eac352c48d66309743
                            
                    
Instance: bundlepackageleaflet-da-5a0e77a26a98f2eac352c48d66309743
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for lumeblue Package Leaflet for language da"
Description: "ePI document Bundle for lumeblue Package Leaflet for language da"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #da

// Composition
* entry[0].fullUrl = "Composition/composition-da-5a0e77a26a98f2eac352c48d66309743"
* entry[0].resource = composition-da-5a0e77a26a98f2eac352c48d66309743

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mp5a0e77a26a98f2eac352c48d66309743"
* entry[=].resource = mp5a0e77a26a98f2eac352c48d66309743
                            
                    



Instance: mp5a0e77a26a98f2eac352c48d66309743
InstanceOf: MedicinalProductDefinitionUvEpi
Title: "Medicinal Product Lumeblue 25 mg prolonged-release tablets"
Description: "Lumeblue 25 mg prolonged-release tablets"
Usage: #inline

 
* identifier[+].system = "http://ema.europa.eu/identifier"
* identifier[=].value = "EU/1/20/1470/001"
* type = http://hl7.org/fhir/medicinal-product-type#MedicinalProduct "Medicinal Product"

* domain = http://hl7.org/fhir/medicinal-product-domain#Human "Human use"

* status = http://hl7.org/fhir/publication-status#active "active"



* legalStatusOfSupply = $spor-rms#100000072084 "Medicinal product subject to medical prescription"

* name
  * productName = "Lumeblue 25 mg prolonged-release tablets"
  * type = $spor-productNamePartType-cs#220000000001 "Full name" 
  
  * part[0]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000002 "Invented name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000003 "Scientific name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000004 "Strength part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000005 "Pharmaceutical dose form part"
  
  * usage
    * country = urn:iso:std:iso:3166#EU "EU"
    * jurisdiction = urn:iso:std:iso:3166#EU "EU"
    * language = urn:ietf:bcp:47#en  "en"



RuleSet: 5a0e77a26a98f2eac352c48d66309743ListRuleset

* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* identifier[+].system = "http://spor.ema.europa.eu/v2/medicine-name"
* identifier[=].value = "lumeblue"

* status = #current
* mode = #working

* title = "List of all ePIs associated with lumeblue"

* subject = Reference(mp5a0e77a26a98f2eac352c48d66309743)
* subject.extension[0].url = "http://ema.europa.eu/fhir/extension/medicine-name"
* subject.extension[=].valueCoding = $100000000005#lumeblue "lumeblue"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/marketing-authorization-holder"
* subject.extension[=].valueCoding = $100000000005#mah-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/active-substance"
* subject.extension[=].valueCoding = $100000000005#acive-substance-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/domain"
* subject.extension[=].valueCoding = $100000000004#100000000012 "H"

* date = "2015-02-07T13:28:17Z"


* entry[+]
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-en-5a0e77a26a98f2eac352c48d66309743) // lumeblue en
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "en"



* entry[+]
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-da-5a0e77a26a98f2eac352c48d66309743) // lumeblue da
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "da"




Instance: List-5a0e77a26a98f2eac352c48d66309743
InstanceOf: List

* insert 5a0e77a26a98f2eac352c48d66309743ListRuleset
    